J. Dupuis

发表

Paradoxical decrease in circulating neuropeptide Y-like immunoreactivity during mild orthostatic stress in subjects with and without congestive heart failure.

J. Rouleau, J. de Champlain, G. Derchi, 1993, European heart journal.

Kinetics of pulmonary uptake of serotonin during exercise in dogs.

J. Rouleau, C. Goresky, G. Bach, 1996, Journal of applied physiology.

Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine.

J. Rouleau, J. Dupuis, R. Lemieux, 1990, Journal of the American College of Cardiology.

Captopril does not prevent nitroglycerin tolerance in heart failure.

J. Rouleau, D. Bichet, J. Dupuis, 1990, The Canadian journal of cardiology.

β-Adrenergic signal transduction and contractility in the canine heart after cardiopulmonary bypass1

J. Rouleau, Xiao‐ping Yang, M. Anand-Srivastava, 1997 .

Beta-adrenergic signal transduction and contractility in the canine heart after cardiopulmonary bypass.

J. Rouleau, M. Anand-Srivastava, H. Gosselin, 1997, Cardiovascular research.

LU135252, an endothelin(A) receptor antagonist did not prevent pulmonary vascular remodelling or lung fibrosis in a rat model of myocardial infarction.

J. Rouleau, Q. Nguyen, F. Colombo, 2000, British journal of pharmacology.

b -Adrenergic signal transduction and contractility in the canine heart after cardiopulmonary bypass 1

J. Rouleau, M. Anand-Srivastava, H. Gosselin, 1997 .

Pulmonary angiotensin-converting enzyme substrate hydrolysis during exercise.

J. Rouleau, C. Goresky, G. Bach, 1992, Journal of applied physiology.

Use of norepinephrine uptake to measure lung capillary recruitment with exercise.

J. Rouleau, C. Rose, C. Goresky, 1990, Journal of applied physiology.

Sustained beneficial effect of a seventy-two hour intravenous infusion of nitroglycerin in patients with severe chronic congestive heart failure.

J. Rouleau, D. Bichet, R. Lebeau, 1990, American heart journal.

Fourteen-days Evolution of COVID-19 Symptoms During the Third Wave in Non-vaccinated Subjects and Effects of Hesperidin Therapy: A randomized, double-blinded, placebo-controlled study.

J. Tardif, M. Guertin, J. Morán, 2021, medRxiv.